Immunology of human schistosomiasis: off the beaten path (Q36247378)

13 August 2017

1 reference

title

Immunology of human schistosomiasis: off the beaten path (English)

1 reference

13 August 2017

0 references

1 reference

Secor WE

1 reference

13 August 2017

publication date

1 July 2005

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

issue

7-8

1 reference

13 August 2017

page(s)

309-316

1 reference

Interleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasis

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Morbidity in schistosomiasis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Haemostatic abnormalities in hepatosplenic schistosomiasis mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Anemia of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Increased ratio of tumor necrosis factor-alpha to interleukin-10 production is associated with Schistosoma haematobium-induced urinary-tract morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Role of IL-10 for induction of anemia during inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Dexamethasone treatment improves morphological and hematological parameters in chronic experimental schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Metabolic responses to cachectin/TNF. A brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Mechanisms involved in the anaemia of schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Immune activation is a dominant factor in the pathogenesis of African AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Could control of soil-transmitted helminthic infection influence the HIV/AIDS pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Increased density of human immunodeficiency virus type 1 coreceptors CCR5 and CXCR4 on the surfaces of CD4(+) T cells and monocytes of patients with Schistosoma mansoni infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Increased prevalence of leukocytes and elevated cytokine levels in semen from Schistosoma haematobium-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Female genital schistosomiasis: facts and hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Assessment of eosinophil cationic protein as a possible diagnostic marker for female genital schistosomiasis in women living in a Schistosoma haematobium endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Schistosomiasis co-infection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Associations between anti-Schistosoma mansoni and anti-Plasmodium falciparum antibody responses and hepatosplenomegaly, in Kenyan schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Eosinophilia and progression to active tuberculosis in HIV-1-infected Ugandans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Drugs for the control of parasitic diseases: current status and development in schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

The impact of chemotherapy on morbidity due to schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Seeking the ghost of worms past

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Immunoregulation and World Health Assembly resolution 54.19: why does treatment control morbidity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Contrasting cellular responses in Schistosoma haematobium infected and exposed individuals from areas of high and low transmission in Zimbabwe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Analysis of the 5q31-q33 locus shows an association between IL13-1055C/T IL-13-591A/G polymorphisms and Schistosoma haematobium infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Are the cellular immune responses of children and adults with Schistosoma mansoni infection intrinsically different? Cytokines produced ex vivo in response to antigens and mitogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Familial resemblance in humoral immune response to defined and crude Schistosoma mansoni antigens in an endemic area in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Clinical and Immunologic Evaluation of 31 Patients with Acute Schistosomiasis mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31–q33

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Juvenile Rhesus Monkeys Have Lower Type 2 Cytokine Responses than Adults after Primary Infection withSchistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2005.00778.X

10.1111/J.1365-3024.2005.00778.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference